Pharmacovigilance systems operate through the collection and analysis of data related to adverse drug reactions (ADRs) and other drug-related issues. This data is gathered from various sources, including healthcare providers, patients, and pharmaceutical companies. The key components of these systems include:
Data Collection: Gathering reports of ADRs and other drug-related problems. Data Analysis: Evaluating the collected data to identify trends and potential safety issues. Risk Assessment: Assessing the severity and frequency of identified risks. Risk Management: Implementing strategies to mitigate identified risks. Communication: Disseminating information about drug safety to healthcare providers and the public.
